share_log

China BlueChemical (HKG:3983) Has More To Do To Multiply In Value Going Forward

China BlueChemical (HKG:3983) Has More To Do To Multiply In Value Going Forward

中國藍化學(HKG: 3983)要在未來的價值成倍增長方面還有更多工作要做
Simply Wall St ·  03/22 19:11

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. Having said that, from a first glance at China BlueChemical (HKG:3983) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look.

如果我們想找到潛在的多袋裝貨商,通常有潛在的趨勢可以提供線索。在一個完美的世界中,我們希望看到一家公司向其業務投入更多資本,理想情況下,從這些資本中獲得的回報也在增加。歸根結底,這表明這是一家以更高的回報率對利潤進行再投資的企業。話雖如此,乍一看中國藍化學(HKG: 3983),我們並不是對回報的趨勢不屑一顧,但讓我們更深入地了解一下。

Return On Capital Employed (ROCE): What Is It?

資本使用回報率(ROCE):這是什麼?

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. The formula for this calculation on China BlueChemical is:

對於那些不知道的人來說,ROCE是衡量公司年度稅前利潤(其回報率)的指標,相對於該業務使用的資本。在中藍化工上進行此計算的公式爲:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

已動用資本回報率 = 息稅前收益 (EBIT) ¥(總資產-流動負債)

0.072 = CN¥1.5b ÷ (CN¥24b - CN¥3.1b) (Based on the trailing twelve months to June 2023).

0.072 = 人民幣 150b ε (24b cn¥24b-cn¥31b) (基於截至 2023 年 6 月的過去十二個月)

Thus, China BlueChemical has an ROCE of 7.2%. Ultimately, that's a low return and it under-performs the Chemicals industry average of 9.1%.

因此,中國藍化集團的投資回報率爲7.2%。歸根結底,這是一個低迴報,其表現低於化工行業9.1%的平均水平。

roce
SEHK:3983 Return on Capital Employed March 22nd 2024
SEHK: 3983 2024 年 3 月 22 日動用資本回報率

In the above chart we have measured China BlueChemical's prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for China BlueChemical .

在上圖中,我們將中國藍化先前的投資回報率與之前的表現進行了對比,但可以說,未來更爲重要。如果你想了解分析師對未來的預測,你應該查看我們爲China BlueChemical提供的免費分析師報告。

What The Trend Of ROCE Can Tell Us

ROCE 的趨勢能告訴我們什麼

The returns on capital haven't changed much for China BlueChemical in recent years. The company has consistently earned 7.2% for the last five years, and the capital employed within the business has risen 32% in that time. This poor ROCE doesn't inspire confidence right now, and with the increase in capital employed, it's evident that the business isn't deploying the funds into high return investments.

近年來,中藍化工的資本回報率沒有太大變化。在過去五年中,該公司的收入一直保持在7.2%,在此期間,公司內部使用的資本增長了32%。這種糟糕的投資回報率目前並不能激發信心,隨着所用資本的增加,很明顯,該企業沒有將資金部署到高回報的投資中。

Our Take On China BlueChemical's ROCE

我們對中國藍化投資回報率的看法

Long story short, while China BlueChemical has been reinvesting its capital, the returns that it's generating haven't increased. Unsurprisingly, the stock has only gained 27% over the last five years, which potentially indicates that investors are accounting for this going forward. Therefore, if you're looking for a multi-bagger, we'd propose looking at other options.

長話短說,儘管中國藍化一直在對其資本進行再投資,但其產生的回報並未增加。毫不奇怪,該股在過去五年中僅上漲了27%,這可能表明投資者正在考慮未來的情況。因此,如果您正在尋找多袋機,我們建議您考慮其他選項。

Since virtually every company faces some risks, it's worth knowing what they are, and we've spotted 2 warning signs for China BlueChemical (of which 1 is a bit unpleasant!) that you should know about.

由於幾乎每家公司都面臨一些風險,因此值得了解它們是什麼,我們已經發現了中國藍化集團的兩個警告信號(其中一個有點不愉快!)你應該知道的。

If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity.

如果你想尋找收益豐厚的穩健公司,可以免費查看這份資產負債表良好且股本回報率可觀的公司名單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論